SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640455-21-000007
Filing Date
2021-01-11
Accepted
2021-01-11 06:19:15
Documents
1
Period of Report
2021-01-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161036394250737.html 4  
1 FORM 4 wf-form4_161036394250737.xml 4 5650
  Complete submission text file 0001640455-21-000007.txt   7022
Mailing Address C/O ARIAD PHARMACEUTICALS, INC 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Cole Hugh M (Reporting) CIK: 0001604646 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37998 | Film No.: 21519025

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)